Douglas Bruce Kell

Title: Douglas Bruce Kell: Innovator in Medical Detection and Treatment

Introduction

Douglas Bruce Kell is a prominent inventor based in Manchester, GB. He has made significant contributions to the field of medical diagnostics and treatment, holding 2 patents that focus on innovative methods for detecting inflammation and treating Alzheimer's disease.

Latest Patents

One of his latest patents is a method of detecting inflammation. This method involves determining the quantity of amyloid present in fibrin(ogen) protein in a blood sample obtained from a subject. Based on the quantity of fibrin(ogen) amyloid determined, a level of inflammation in the subject is assigned. Additionally, the patent includes a method for determining the effect of therapeutic treatment on a subject by comparing pre-treatment and post-treatment levels of inflammation. Another significant patent is for a method of treating Alzheimer's disease. This method includes administering a therapeutically effective amount of lipopolysaccharide-binding protein (LBP) to a subject suffering from the disease. A composition containing a therapeutically effective amount of LBP is also provided in this patent.

Career Highlights

Douglas Bruce Kell is affiliated with Stellenbosch University, where he continues to engage in research and innovation. His work has been instrumental in advancing medical science, particularly in the areas of inflammation detection and Alzheimer's treatment.

Collaborations

He has collaborated with notable colleagues, including Etheresia Pretorius and Willem Johan Simon De Villiers, contributing to a rich environment of innovation and research.

Conclusion

Douglas Bruce Kell's contributions to medical diagnostics and treatment exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving patient outcomes through scientific advancement.